Vasopressin and Terlipressin in the Treatment of Vasodilatory Septic Shock: A Systematic Review
Background: Vasodilatory septic shock unresponsive to fluid resuscitation requires the addition of vasopressors. Catecholamines remain the first line vasopressor therapy, but treatment failure is a potential problem. Vasopressin and its analogue, terlipressin, have been used for this indication. Obj...
Main Authors: | Jie Lin Soong BSc (Pharm) (Hons), Wai Hing Lim B Pharm (Hons), M Clin Pharm |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2011-09-01
|
Series: | Proceedings of Singapore Healthcare |
Online Access: | https://doi.org/10.1177/201010581102000310 |
Similar Items
-
Phenytoin: A Guide to Therapeutic Drug Monitoring
by: Melissa Faye Wu BSc (Pharm) (Hons), et al.
Published: (2013-09-01) -
Terlipressin for the treatment of septic shock in adults: a systematic review and meta-analysis
by: Lili Huang, et al.
Published: (2020-03-01) -
Terlipressin Versus Norepinephrine for Septic Shock: A Systematic Review and Meta-Analysis
by: Po Huang, et al.
Published: (2019-12-01) -
Vasopressin and septic shock
by: Sarah Mousavi
Published: (2015-10-01) -
Use of Arginine Vasopressin in the Management of Vasodilatory Shock After CABG - A Clinical Tria.
by: Sanjay O, et al.
Published: (2003-01-01)